Intervention Review

Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis

  1. John A Corless1,*,
  2. Chris J Warburton2

Editorial Group: Cochrane Airways Group

Published Online: 24 APR 2000

Assessed as up-to-date: 4 MAY 2011

DOI: 10.1002/14651858.CD002174

How to Cite

Corless JA, Warburton CJ. Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis. Cochrane Database of Systematic Reviews 2000, Issue 2. Art. No.: CD002174. DOI: 10.1002/14651858.CD002174.

Author Information

  1. 1

    Whiston Hospital, Prescott, Merseyside, UK

  2. 2

    University Hospital, Aintree Chest Centre, Aintree, Liverpool Merseyside, UK

*John A Corless, Whiston Hospital, Warrington Road, Prescott, Merseyside, L35 5DR, UK.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 24 APR 2000


Cited in:


This article has been cited by:

  1. 1
    Charles Feldman, The Use of Antiinflammatory Therapy and Macrolides in Bronchiectasis, Clinics in Chest Medicine, 2012, 33, 2, 371


  2. 2
    Charles Feldman, Bronchiectasis: New Approaches to Diagnosis and Management, Clinics in Chest Medicine, 2011, 32, 3, 535


  3. 3
    Gregory J. Redding, Bronchiectasis in Children, Pediatric Clinics of North America, 2009, 56, 1, 157


  4. 4
    Gregory J. Redding, Catherine A. Byrnes, Chronic Respiratory Symptoms and Diseases Among Indigenous Children, Pediatric Clinics of North America, 2009, 56, 6, 1323


  5. You have free access to this content5
    Kenneth W. TSANG, Diana BILTON, Clinical challenges in managing bronchiectasis, Respirology, 2009, 14, 5
  6. 6
    A.M.ª Calderón González, Tratamiento médico de las bronquiectasias: evidencia científica, Rehabilitación, 2005, 39, 2, 70


  7. 7
    Emma J Welsh, Sally Spencer, Tarek Saba, David J Evans, Stephen J Fowler, Interventions for bronchiectasis: an overview of Cochrane systematic reviews, The Cochrane Library,